Status and phase
Conditions
Treatments
About
Study of the effects of intranasal sufentanil on patients presenting to the emergency department with acute post-traumatic pain.
Full description
In this study, patients presenting to the emergency department with post-traumatic pain of 7 or more on the visual analog pain scale, since less than 24 hours, in the limbs, spine or thorax are randomized in a control arm or an interventional arm.
The patients in the control arm will receive the institution's classical analgetic protocol level 1 and 3, the patients in the intervention arm are given classical level 1 medication as well as intranasal Sufentanil.
Pain is then measured using the Visual Analogue Pail Scale at 15-20 minutes and at 60 minutes. At both these time points, adverse effects and vitals are also assessed.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
170 participants in 2 patient groups
Loading...
Central trial contact
Stefano Malinverni, MD; Bernard Kreps, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal